Sandoz Beats UK AirFluSal Passing-Off Charge

The Color Purple: GSK’s Seretide has no monopoly on purple packaging

Purple smoke
Justice Richard Arnold cut through the fog to find there was no basis for alleging that Sandoz is passing off its AirFluSal Forspiro inhalers in the UK as GlaxoSmithKline’s Seretide • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin